SEC Filings for Arrowhead Pharmaceuticals Inc. (ARWR)

$ 38.49   -1.25 (-3.15%) Volume: 1.06m 4:00 PM EST Feb 21, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities102/19/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals1002/14/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/13/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals502/12/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)3102/05/2020
8-KCurrent report pursuant to Section 13 or 15(d)702/05/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/04/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/04/2020
DEF 14AOther definitive proxy statements6201/28/2020
4Statement of changes in beneficial ownership of securities101/23/2020
PRE 14APreliminary proxy statement providing notification matters to be brought to a vote6201/14/2020
3Initial statement of beneficial ownership of securities101/13/2020
4Statement of changes in beneficial ownership of securities101/08/2020
4Statement of changes in beneficial ownership of securities101/08/2020
4Statement of changes in beneficial ownership of securities101/08/2020
<<
First
<
Prev
123456789101112131415